In Canada's next General Election, which could be as soon as June,pharmaceuticals could become a major issue, with a possible election promise to include drugs as part of Medicare. The incumbent Liberal government has said it is considering offering voters a C$2 billion ($2.43 billion) national "pharmacare" program as a way of combating the escalating cost of medicines.
The idea is backed by the generics industry, whose trade body, the Canadian Drug Manufacturers Association, has said it would want to be involved in implementing the plan. The research-based drugmakers also support the concept of pharmacare as part of the overall health system, said Judy Erola, president of the Pharmaceutical Manufacturers Association of Canada.
Ms Erola noted, however, that most Canadians already enjoy drug coverage and, while the PMAC backs the principle, "the devil is in the detail." For generics firms, CDMA president Brenda Drinkwalter has stressed that the pharmacare program would require a significant change in Bill C-91 on generics, to allow more freedom to copy brand-name drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze